Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-25 @ 10:29 PM
Study NCT ID:
NCT00671658
Status:
COMPLETED
Last Update Posted:
2020-12-03
First Post:
2008-04-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-11
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-30
First Submit QC Date:
None
Study First Post Date:
2008-05-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-11-03
Results First Submit QC Date:
None
Results First Post Date:
2020-12-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-01
Last Update Post Date:
2020-12-03
Last Update Post Date Type:
ACTUAL